Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss

Diabetes

Volumn 56, Issue 3, 2007, Pages 735-742

  Lin, Edward ^a   Phillips, Lawrence S ^a   Ziegler, Thomas R ^a   Schmotzer, Brian ^a   Wu, Kongjun ^a   Gu, Li H ^a   Khaitan, Leena ^a   Lynch, Scott A ^a   Torres, William E ^a   Smith, C Daniel ^a   Gletsu Miller, Nana ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTHROPOMETRY; ARTICLE; BARIATRIC SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE INTOLERANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIVER; METABOLIC PARAMETERS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

ADIPONECTIN; ADIPOSITY; ADULT; BARIATRIC SURGERY; FEMALE; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER; MIDDLE AGED; OBESITY; WEIGHT LOSS;

EID: 33847415067     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-1161     Document Type: Article

References (54)

1. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH: The disease burden associated with overweight and obesity. JAMA 282:1523-1529, 1999
2. Ronti R, Lupattelli G, Mannarino E: The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 64:355-365, 2006
3. Radzuik J: Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 85:4426-4433, 2000
4. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM: Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291:2847-2850, 2004
5. Kvist H, Sjostrom L, Tylen U: Adipose tissue volume determination in women by computed tomography: technical considerations. Int J Obes 10:53-67, 1986
6. Lebovitz HE, Banerji MA: Point: Visceral adiposity is causally related to insulin resistance. Diabetes Care 28:2322-2325, 2005
7. Busetto L, Tregnaghi A, Bussolotto M, Sergi G, Beninca P, Ceccon A, Giantin V, Fiore D, Enzi G: Visceral fat loss evaluated by total body magnetic resonance imaging in obese women operated with laparoscopic adjustable silicone gastric banding. Int J Obes 24:60-69, 2000
8. Sjostrom CD, Lissner L, Sjostrom L: Relationships between changes in body composition and changes in cardiovascular risk factors: The SOS Intervention Study. Obes Res 5:519-530, 1997
9. Gletsu N, Lin E, Khaitan L, Lynch SA, Ramshaw B, Raziano R, Torres WE, Ziegler TR, Papanicolaou DA, Smith CD: Changes in C-reactive protein predict insulin sensitivity in severely obese individuals after weight loss surgery. J Gastrointest Surg 9:1119-1128, 2005
10. Stubbs RS, Wickremesekera SK: Insulin resistance in the severely obese and links with metabolic co-morbidities. Obes Surg 12:343-348, 2002
11. Lin E, Gletsu N, Fugate K, McClusky D, Gu LH, Zhu J-L, Ramshaw BJ, Papanicolaou DA, Ziegler TR, Smith CD: The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch Surg 139:780-784, 2004
12. Brochu M, Starling RD, Tchernof A, Matthews DE, Garcia-Rubi E, Poehlman ET: Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women. J Clin Endocrinol Metab 85:2378-2384, 2000
13. Bergman RN: Toward physiological understanding of glucose tolerance: minimal-model approach. Diabetes 38:1512-1527, 1989
14. Kahn HS, Austin H, Williamson DF, Arensberg D: A simple anthropometric indices associated with ischemic heart disease. J Clin Epidemiol 49:1017-1024, 1996
15. Grundy SM, Brewer HB Jr, Cleeman JL, Smith SC Jr, Lenfant C: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 109:433-438, 2004
16. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen Y-DI, Sands RE, Pei D, Savage PJ, Bergman RN, for the Insulin Resistance Atherosclerosis Study: A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43:1114-1121, 1994
17. Radikova Z, Koska J, Huckova M, Ksinantova L, Imrich R, Vigas M, Trnovec T, Langer P, Sebokova E, Klimes I: Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes 115:249-256, 2006
18. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 29 (Suppl. 1):S43-S48, 2006
19. Camastra S, Manco M, Mari A, Baldi S, Gastaldelli A, Greco AV, Mingrone G, Ferrannini E: B-cell function in morbidly obese subjects during free living: long-term effects of weight loss. Diabetes 54:2382-2389, 2005
20. Greco AV, Mingrone G, Giacaterinini A, Manco M, Morroni M, Cinti S, Granzotto M, Vettor R, Camastra S, Ferannini E: Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51:144-151, 2002
21. Guldstrand M, Ahren B, Adamson U: Improved B-cell function after standardized weight reduction in severely obese subjects. Am J Physiol Endocrinol Metab 284:E557-E565, 2003
22. Houmard JA, Tanner CJ, Yu C, Cunningham PG, Pories WJ, MacDonald KG, Shulman GI: Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes 51:2959-2963, 2002
23. Mingrone G, Rosa G, Di Rocco P, Manco M, Capristo E, Castagneto M, Vettor R, Gasbarrini G, Greco AV: Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-a reduction and GLUT4 expression enhancement. Int J Obes 26:1165-1172, 2002
24. Muscelli E, Mingrove G, Camastra S, Manco M, Pereira JA, Pareja JC, Ferrrannini E: Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am J Med 118:51-57, 2005
25. Vazquez LA, Pazos F, Barrazueta JR, Fernandez-Escalante C, Garcia-Unzueta MT, Freijanes J, Amado JA: Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 90:316-322, 2005
26. Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, Mari A, Nanni G, Castagneto M, Calvani M, Mingrone G: Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55:2025-2031, 2006
27. Jimenez J, Zuniga-Guajardo S, Zinman B, Angel A: Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance and sensitivity. J Clin Endocrinol Metab 64:661-668, 1987
28. Park KG, Park KS, Kim MJ, Kim HS, Suh YS, Ahn JD, Park KK, Chang YC, Lee IK: Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 63:135-142, 2004
29. Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S: Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metab Clin Exp 52:1274-1278, 2003
30. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459-469, 2003
31. Cnop M, Landchild MJ, Vidal J, Havel P, Knowles NG, Carr DR, Wang F, Hull RL, Boyko EJ, Retzlaff BM, Walden CE, Knopp RH, Kahn SE: The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin compartments: distinct metabolic effects of two fat compartments. Diabetes 51:1005-1015, 2002
32. Rissanen P, Makimattila S, Vehmas T, Taavitsainen T, Rissanen A: Effect of weight loss and regional fat distribution on plasma leptin concentration in obese women. Int J Obes 23:645-649, 1999
33. Hayase H, Sachiko N, Takashi A, Tetsuya I: Relation between fat distribution and several plasma adipocytokines after exercise training in premenopausal and postmenopausal women. J Physiol Anthropol Appl Human Sci 21:105-113, 2002
34. van Rossum EF, Nicklas BJ, Dennis KE, Berman DM, Goldberg AP: Leptin responses to weight loss in postmenopausal women: relationship to sex-hormone binding globulin and visceral obesity. Obes Res 8:29-35, 2000
35. Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R: First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 26:819-824, 2003
36. Kopp HP, Kopp CW, Festa A, Krzyzanowska K, Kriwanek S, Minar E, Roka R, Schernthaner G: Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 23:1042-1047, 2003
37. Oberback A, Tonjes A, Kloting N, Fasshauer M, Kratzsch J, Busse MW, Paschke R, Stumvoll M, Bluher M: Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol 154:577-585, 2006
38. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS: Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350:2549-2557, 2004
39. Meyer C, Pimenta W, Woerle HJ, Haeften TV, Szoke E, Mitrakou A, Gerich J: Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29:1909-1914, 2006
40. Tripathy D, Almgren P, Toumi T, Groop L: Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity. Diabetes Care 27:2204-2210, 2004
41. Lihn AS, Pedersen SB, Richelsen B: Adiponectin: action, regulation and association to insulin sensitivity. Obesity Rev 6:13-21, 2005
42. Buemann B, Astrup A, Pederson O, Black E, Holst C, Toubro S, Echwald S, Holst JJ, Rasmussen C, Sorensen TIA: Possible role of adiponectin and insulin sensitivity in mediating the favorable effects of lower body fat mass on blood lipids. J Clin Endocrinol Metab 91:1698-1704, 2006
43. Baratta R, Amato S, Degano C, Farina MG, Patane G, Vigneri R, Frittitta L: Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and interventional studies. J Clin Endocrinol Metab 89:2665-2671, 2004
44. Arawaka N, Daimon M, Oizumi T, Jimbu Y, Kameda W, Yamaguchi H, Ohnuma H, Tominaga M, Kato T: Correlation between change in body weight rather than current body weight and change in serum adiponectin levels in a Japanese population: the Funagata study. Metab Clin Exp 55:324-330, 2006
45. Faraj M, Havel PJ, Phelis S, Blank D, Sniderman AD, Cianflone K: Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88:1594-1602, 2003
46. Xydakis AM, Case CC, Jones PH, Hoogeveen RC, Liu M-Y, O'Brien Smith E, Nelson KW, Ballantyne CM: Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab 89:2697-2703, 2004
47. Yang W-S, Lee W-J, Funahashi T, Tanaka S, Matsukawa Y, Chao C-L, Chen C-L, Tai T-Y, Chuang L-M: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86:3815-3819, 2001
48. Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM: The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51:2968-2974, 2002
49. Calvani M, Scarfone A, Granato L, Mora EV, Nanni G, Castagneto M, Greco AV, Manco M, Mingrone G: Restoration of adiponectin pulsatility in severely obese subjects after weight loss. Diabetes 53:939-947, 2004
50. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Ushida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769, 2003
51. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-943, 2001
52. Andreelli F, Foretz M, Knauf C, Cani PD, Perrin C, Iglesias MA, Pillot B, Bado A, Tronche F, Mithieux G, Vaulont S, Burcelin R, Viollet B: Liver adenosine monophosphate-activated kinase-a2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology 147:2432-2441, 2006
53. Stefan N, Stumvoll M, Vozarova B, Weyer C, Funahashi T, Matsuzawa Y, Bogardus C, Tataranni PA: Plasma adiponectin and endogenous glucose production in humans. Diabetes Care 26:3315-3319, 2003
54. Letiexhe MR, Scheen AJ, Gerard PL, Desaive C, Lefebvre PJ: Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects. Int J Obes 18:295-300, 1994